Crossref

1. Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population

- Zary Nokhodian

- Behrooz Ataei

- Seyed Mohsen Zahraei

- Mohammad Mehdi Gouya

- Shervin Ghaffari Hoseini

- Majid Yaran

- Marjan Mansourian

- Mohammad Esmaeil Motlagh

- Ramin Heshmat

- Roya Kelishadi

2. Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants

- Nisha Makan-Murphy

- Shabir A Madhi

- Ziyaad Dangor

3. Childhood pertussis is still here: An Asian city's perspectives

- Kam Lun E. Hon

- Yee Ming Jennifer Li

- Alexander K. C. Leung

- Alex H. C. Wong

- Karen Ka Yan Leung

- Daniel K. K. Ng

4. Identification of Etiological Agents of Pertussis-Like Syndrome in Children Younger Than 5 Years Old Hospitalized in Southwestern Iran

- Ahmad Shamsizadeh

- Roya Nikfar

- Elham Bavarsadiankhah

- Effat Abbasi-Montazeri

- Niloofar Neisi

- Maniya Arshadi

5. Genetic variability of <i>Bordetella pertussis</i> and its role in vaccine prevention of pertussis

- I. G. Bazhanova

- M. V. Britsina

- N. U. Mertsalova

- M. N. Ozeretskovskaya

6. Prevention of aggregate formation through mechanism analysis in refolding of recombinant pertactin from Escherichia coli

- Zenglan Li

- Chun Zhang

- Yan Zhang

- Yongdong Liu

- Xiunan Li

- Guanghui Ma

- Jian Luo

- Zhiguo Su

7. Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran

- Gaelle Noel

- Farzad Badmasti

- Vajihe S. Nikbin

- Seyed M. Zahraei

- Yoann Madec

- David Tavel

- Mohand Aït-Ahmed

- Nicole Guiso

- Fereshteh Shahcheraghi

- Fabien Taieb

- Abdallah M. Samy

8. Immunogenicity and safety of DTPW-HEPB-HIB (PRP-T) vaccine (Pentavac) in infants aged 2–7 months: a post marketing phase 4 clinical trial study

- H. Masoumi-Asl

- A. Nateghian

- H.R. Baradaran

- E. Jafari

- R. Azizian

- Mahmoud Faramarzi